Literature DB >> 35733231

Correction to: CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington's disease.

Dahyun Yu1, Nicole Zarate1, Angel White1, De'jah Coates1, Wei Tsai1, Carmen Nanclares1, Francesco Cuccu1,2, Johnny S Yue1,3, Taylor G Brown1, Rachel H Mansky1, Kevin Jiang1, Hyuck Kim1,4,5,6, Tessa Nichols-Meade1, Sarah N Larson7, Katherine Gundry7, Ying Zhang8, Cristina Tomas-Zapico9,4,5,6, Jose J Lucas9,10, Michael Benneyworth1, Gülin Öz7, Marija Cvetanovic1, Alfonso Araque1, Rocio Gomez-Pastor11.   

Abstract

Entities:  

Year:  2022        PMID: 35733231      PMCID: PMC9219233          DOI: 10.1186/s40478-022-01397-6

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.578


× No keyword cloud information.

Correction to: Acta Neuropathologica Communications (2022) 10:83 https://doi.org/10.1186/s40478-022-01379-8

Following publication of the original article [1], an error was identified in the corresponding authorship and equal contributions in the author group due to a typesetting mistake: the third author, Angel White, should have been indicated as equal contributor, instead of as corresponding author. The author group has been updated above and the original article [1] has been corrected. The publisher apologises to the authors and readers for the inconvenience caused by the error.
  1 in total

1.  CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's disease.

Authors:  Dahyun Yu; Nicole Zarate; Angel White; De'jah Coates; Wei Tsai; Carmen Nanclares; Francesco Cuccu; Johnny S Yue; Taylor G Brown; Rachel H Mansky; Kevin Jiang; Hyuck Kim; Tessa Nichols-Meade; Sarah N Larson; Katherine Gundry; Ying Zhang; Cristina Tomas-Zapico; Jose J Lucas; Michael Benneyworth; Gülin Öz; Marija Cvetanovic; Alfonso Araque; Rocio Gomez-Pastor
Journal:  Acta Neuropathol Commun       Date:  2022-06-03       Impact factor: 7.578

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.